| Allgemeine Literatur |
| [1] |
Breitenecker G, Lax S. Tumoren des Corpus
uteri. in: Holzner JH et al. (ed.) Histologische Tumorklassifikation
der Österreichischen Gesellschaft für Pathologie. Springer
Verlag 1994. |
| [2] |
Burghardt, E: Surgical Gynecologic Oncology
Thieme Verlag 1993 |
| [3] |
Gompel C, Silverberg St G. Pathology in
Gynecology and Obstetrics. 4th edition. Chapter 4, The
Corpus Uteri pp163-284. J B Lippincott Company, Philadelphia,
1994. |
| [4] |
Kurman RJ (editor) Blaustein's Pathology
of the Female Genital Tract. 3rd edition Springer Verlag
1987. |
| [5] |
Talerman A. Ovarian Pathology. Current
Opinion in Obstetrics and Gynecology 4: 608-15, 1992. |
| [6] |
TNM Classification of Malignant Tumours.
4th edition, 2nd revision 1992. Springer Verlag. |
| [7] |
TNM Atlas. Illustrated Guide to the TNM/pTNM
Classification of Malignant Tumours. 3rd edition, 2nd
revision 1992. Springer Verlag. |
| [8] |
TNM Supplement 1993. A Commentary on Uniform
Use. Springer Verlag. |
| Originalarbeiten: |
| [1] |
Bell DA, Weinstock MA, Scully RE. Peritoneal
implants of ovarian serous borderline tumors. Cancer 62:
2212-2222, 1988. |
| [2] |
Bell DA, Scully RE. Ovarian serous borderline
tumors with stromal microinvasion. A report of 21 cases.
Hum Pathol 21: 397-403, 1990. |
| [3] |
Breitenecker G, Bartl W, Endler Margit,
Gring H. Die prognostische Bedeutung morphologischer Parameter
bei Endometriumkarzinomen. Onkologie 7: 222-235, 1984 |
| [4] |
Burks RT, Sherman ME, Kurman RJ. Micropapillary
serous carcinoma of the ovary. A distinctive low grade
carcinoma related to serous borderline tumors. Am J Surg
Pathol 1996; 20: 1319-1330 |
| [5] |
Casagrande JT, Pike MC, Ross RK et al.
"Incessant ovulation" and ovarian cancer. Lancet
1979; 2:170. |
| [6] |
Cramer DW et al. Factors affecting the
association of oral contraceptives and ovarian cancer.
N Engl J Med 1982; 307:1047. |
| [7] |
Cramer DW et al. Mumps, menarche , menopause
and ovarian cancer. Am J Obstet Gynecol 1983;147:1. |
| [8] |
Cramer DW et al. Dietary animal fat in
relation to ovarian cancer risk. Obstet Gynecol 1984;
63:883. |
| [9] |
Harlow BL, Fuhr JE, McDonald ThW et al.
Flow Cytometry as a Prognostic Indicator in Women with
Borderline Epithelial Ovarian Tumors. Gynecologic Oncology
50: 305-309, 1993. |
| [10] |
Henderson BE, Pike MC, Ross RK et al. Endogenous
hormones as a major factor in human cancer. Cancer Res
1982; 42: 3232. |
| [11] |
Kvale G, Heuch I, Nilssen S et al. Reproductive
factors and risk of ovarian cancer: A prospective study.
Int J Cancer 1989; 42:246. |
| [12] |
Lynch HT et al. Familial ovarian carcinoma.
Am J Med 81: 1073, 1986. |
| [13] |
Lynch HT et al. Hereditary carcinoma of
the ovary and associated cancers: A study of two families.
Gynecol Oncol 36: 48, 1990. |
| [14] |
McGuire WP, Hoslins WJ, Brady MF, Kucera
PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson
M. Cyclophosphamide and cisplatin compared with paclitaxel
and cisplatin in patients with stage III and stage IV
ovarian cancer. N Engl J Med 1996:334:1-6 |
| [15] |
Petru E, Lahousen M, Tamussino K, Pickel
H, Stranzel H, Stettner H, Winter R. Lymphadenectomy in
Stage I ovarian cancer. Am J Ostet Gynecol 1994, 170:656-662 |
| [16] |
Seidman JD, Norris HJ, Griffin JL et al.
DNA Flow Cytometric Analysis of Serous Ovarian Tumors
of Low Malignant Potential. Cancer 71: 3947-51, 1993. |
| [17] |
Seidman JD, Kurman RJ. Subclassification
of serious borderline tumors of the ovary into benign
and malignant types. A clinicopathological study of 65
advanced stage cases. Am J Surg Pathol 1996; 20: 1331-1345 |
| [18] |
Tavassoli FA. Serous tumor of low malignant
potential with early stromal invasion (serous LMP with
microinvasion). Mod Pathol 1: 407-414, 1988. |
| [19] |
Wu ML, Whittemore AS et al. Personal and
environmental characteristicsrelated to epithelial ovarian
cancer. Am J Epidemiol 1988;128:1216 |
